Finnair’s Q4 revenue hit estimates well, while adjusted EBIT was a bit stronger than expected.
Mangold inleder bevakning av VIMAB Group med köprekommendation och en riktkurs på 22,20 kronor per a...
Redeye provides its initial take on Genovis’ Q4 2022 report, which came in substantially below our e...
Redeye comments on GiG’s Q4-results which came in somewhat higher than forecasted driven by strong p...
Redeye comments in Carasent's Q4 2022 report, which came in above our estimates on the ARR and net s...
Redeye comments on M.O.B.A. Network’s Q4 2022 report.
Occupancy rate up to 92.5% (91.1%) Focus on deleveraging during 2023 2023e P/CEPS of 20x and NAV dis...
Redeye comments on Energy Save’s directed right issue of cSEK151.
Redeye retains its positive view of Vertiseit following a solid Q4 report with strong System sales a...
Redeye is encouraged to see that Catella delivered a solid Q4 2022 report, despite a challenging rea...
Redeye remains confident in the case as Q4 numbers validate positive trends in both business segment...
The availability of electronic components has improved and end demand has been relatively healthy, s...
Operationally sound Diös delivered a Q4 report with rental income -2% vs ABGSCe.
Redeye comments on Hoylu’s rights issue that was revealed yesterday, proposing a fully secured right...
2022 blev ett rekordår för Nimbus som såg stark tillväxt utanför Norden.
Förvärvet av Roper Rhodes lyfter övriga koncernen under kvartalet.
Analysguiden inleder bevakning av medicinteknikbolaget iZafe med motiverat värde 0,3 kr.
Raute’s Q4 revenue was clearly higher than we estimated, whereas EBIT was on the soft side especiall...
